La investigación en Pediatría en España: retos y prioridades. Plataforma INVEST-AEP

[1]  B. Garrido-Corro,et al.  Utilización de medicamentos fuera de ficha técnica y sin licencia en una Unidad de Cuidados Intensivos Neonatales española , 2017 .

[2]  B. Garrido-Corro,et al.  Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit. , 2017, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

[3]  C. O’Donnell,et al.  Unlicensed and off‐label drug use in an Irish neonatal intensive care unit: a prospective cohort study , 2014, Acta paediatrica.

[4]  A. Nowak.  [Conference 3. European directive on the cross-border health care: implementation in reference European network]. , 2014, Medecine sciences : M/S.

[5]  L. E. Peterson,et al.  Pediatric collaborative networks for quality improvement and research. , 2013, Academic pediatrics.

[6]  G. Cummings,et al.  Establishing a multicentre clinical research network: lessons learned. , 2011, Current oncology.

[7]  A. Martini,et al.  Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO) , 2011, Archives of Disease in Childhood.

[8]  R. Wasserman,et al.  Pediatric Clinical Research Networks: Current Status, Common Challenges, and Potential Solutions , 2010, Pediatrics.

[9]  Phyllis N Butow,et al.  Clinical trials in children , 2004, The Lancet.

[10]  S. Conroy,et al.  Unlicensed and off label drug use in neonates , 1999, Archives of disease in childhood. Fetal and neonatal edition.